Interleukin 1 protects against 1-beta-D-arabinofuranosylcytosine-induced alopecia in the newborn rat animal model.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Cancer Research

• Publication date

  1991-06-15

• Fields of study

  Medicine

• Identifiers
  PMID 2040008
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice.

  1991cited by this paper
• Interleukin-1 alpha protects against the toxicity associated with combined radiation and drug therapy.

  1991cited by this paper
• Synergism of ara-C-imuvert combination in aborting the development of transplanted chloroleukemia in the rat.

  1991cited by this paper
• Interleukin-1 enhances epidermal wound healing.

  1990cited by this paper
• Protection from chemotherapy-induced alopecia in a rat model.

  1990cited by this paper
• Interleukin-1 accelerates murine granulocyte recovery following treatment with cyclophosphamide.

  1989cited by this paper
• Human interleukin-1 alpha is chemotactic for normal human keratinocytes.

  1989cited by this paper
• Interleukin 1.

  1989cited by this paper
• Doxorubicin-induced hair loss in the Angora rabbit: a study of treatments to protect against the hair loss

  1987cited by this paper
• Interleukin 1 is a radioprotector.

  1986cited by this paper
• Prevention of doxorubicin-induced hair loss with scalp hypothermia.

  1979cited by this paper

• 5 Chemotherapy-Induced Alopecia

  2018cites this paper
• Risk of Distinctive Hair Changes Associated With Pazopanib in Patients With Renal Cell Carcinoma (RCC) Versus Patients Without RCC: A Comparative Systematic Review and Meta‐analysis

  2017cites this paper
• Hair Disorders Associated with Anticancer Agents

  2013cites this paper
• Chemotherapy-induced alopecia

  2012cites this paper
• Treatment of chemotherapy‐induced alopecia

  2011cites this paper
• Prevention of chemotherapy-induced alopecia by the anti-death FNK protein.

  2008influential citation
• Mechanism of the Protective Effect of Intraperitoneally Administered Agonists for Formyl Peptide Receptors against Chemotherapy-Induced Alopecia

  2007cites this paper
• Broad-Spectrum Protection Against Chemotherapy-Induced Alopecia by Acidic and Basic Fibroblast Growth Factors

  2005cites this paper
• Molecular mechanisms of chemotherapy-induced hair loss.

  2003cites this paper
• A practitioner's guide to cancer-related alopecia.

  1998cites this paper
• A review of tumor suppressor genes in cutaneous neoplasms with emphasis on cell cycle regulators.

  1998cites this paper
• Effects of interleukins, colony‐stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin‐1 and tumour necrosis factor‐α in alopecia areata

  1996cites this paper
• PROTECTION AGAINST CYTOSINE ARABINOSIDE‐INDUCED ALOPECIA BY MINOXIDIL IN A RAT ANIMAL MODEL

  1995cites this paper
• Protection against chemotherapy-induced alopecia by cyclosporin A in the newborn rat animal model.

  1995cites this paper
• Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.

  1994cites this paper
• Chemotherapy-Induced Alopecia: New Developments

  1993cites this paper
• Protection against cyclophosphamide‐induced alopecia by sulfhydryl‐containing agents in the newborn rat animal model

  1993cites this paper
• Phase II trial of 4′‐O‐tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma

  1992cites this paper